Institutional investors purchased a net $793.8 thousand shares of CRTX during the quarter ended March 2013. This may signal that the smart money is gaining interest in this company as the 12.88% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Other institutional | 9.71% |
| Individual stakeholders | 65.00% |
| Mutual fund holders | 3.17% |